Drug recall · March 9, 2022
Dexamethasone Elixir recall
Why: Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.
- Lots / codes
Lot #s: UV1004, UV1005, Exp 6/22; UW1014, UW1015, Exp 1/23; UW1084, Exp 7/23
- Company
- Morton Grove Pharmaceuticals, Inc., Morton Grove, IL
- Distribution
- Nationwide USA and Puerto Rico
- Initiated
- February 21, 2022 · Voluntary: Firm initiated
- Classified
- March 21, 2022
- Reported
- March 9, 2022
- Ended
- August 6, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dexamethasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.